[HTML][HTML] New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models
A Lopes, C Bastiancich, M Bausart, S Ligot… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Strategies to increase nucleic acid vaccine immunogenicity are needed to
move towards clinical applications in oncology. In this study, we designed a new generation …
move towards clinical applications in oncology. In this study, we designed a new generation …
[HTML][HTML] Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site
A Lopes, S Feola, S Ligot, M Fusciello… - … for immunotherapy of …, 2019 - Springer
Background DNA vaccines against cancer held great promises due to the generation of a
specific and long-lasting immune response. However, when used as a single therapy, they …
specific and long-lasting immune response. However, when used as a single therapy, they …